Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
European Psychiatry : the Journal of the Association of European Psychiatrists|June 18, 2013
Improved quality of life over one year is associated with improved adherence in patients with schizophreniaK P Hayhurst, R J Drake, J A Massie, et al.
Neurology|July 27, 2005
Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trialB K Puri, B R Leavitt, M R Hayden, et al.
Psychopharmacology|July 8, 2003
Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studiesV S Gabrovska-Johnson, M Scott, S Jeffries, et al.
Acta Psychiatrica Scandinavica|August 18, 2010
Experience sampling research in individuals with mental illness: reflections and guidanceJ E Palmier-Claus, I Myin-Germeys, E Barkus, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1993
Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis StudyP B Jones, P Bebbington, A Foerster, et al.
Schizophrenia Research|March 1, 1996
Family history of autoimmune diseases in psychosisC M Gilvarry, P C Sham, P B Jones, et al.
Psychological Medicine|May 4, 2017
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trialJ Lees, P G Michalopoulou, S W Lewis, et al.
Health Technology Assessment (Winchester, England)|May 19, 2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatmentS W Lewis, L Davies, P B Jones, et al.
Lancet (London, England)|May 21, 1999
Brain structure and neurocognitive and behavioural function in adolescents who were born very pretermA L Stewart, L Rifkin, P N Amess, et al.
Psychological Medicine|July 14, 2015
Negative cognition, affect, metacognition and dimensions of paranoia in people at ultra-high risk of psychosis: a multi-level modelling analysisA P Morrison, N Shryane, D Fowler, et al.
Pageof 20